Vaccine Development Global Program

Developing new, affordable vaccines for the people who need them most

Vaccines are one of the most effective, affordable, and beneficial tools in public health. Because market forces alone are not always strong enough to drive the development of vaccines most urgently needed in lower-income countries, PATH’s Vaccine Development Global Program is stepping in to fill the gap. Find out more »

The World Health Organization prequalifies meningitis A vaccine for infants

Infant sleeping in a carrier on a woman's back.   Launch of MenAfriVacThe World Health Organization has opened the door to routine immunization of infants in sub-Saharan Africa by approving for use MenAfriVac®, an innovative and affordable vaccine that has all but rid the meningitis belt of a major cause of deadly epidemics.  Read the blog » Read the press release »

Photo credit: PATH/Gabe Bienczycki


in the news: PATH and Affinivax collaborate to advance innovative technology for pneumococcal vaccines »

update: New collaboration to support influenza vaccine development in China (PDF 65.12 KB) »

update: Partnership extended to support rotavirus vaccine development in China (link in Chinese) »  English translation (PDF 37.3 KB) »

blog: is five years old! Read the blog series »


Sign up for our e-newsletter

Our e-newsletter, Vaccines for the Future, provides quarterly updates on our efforts to develop innovative, safe, effective, and affordable vaccines. It includes updates on our progress, partnerships, and specific activities. Sign up now »

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. Learn more »

Banner photos, clockwise from left: PATH/Gabe Bienczycki; PATH/Chutima Suraratdecha; PATH.

Comments are closed.